54127-59-2Relevant academic research and scientific papers
VASODILATORS AND BETA-ADRENOCEPTOR ANTAGONISTS
-
, (2008/06/13)
This invention relates to dihydropyridazinone compounds having a cyclopropylmethoxyethyl group in the 6-substituent. These compounds are vasodilators and β-adrenoceptor antagonists. A particular compound of the invention is 6-4-3-2-hydroxy-3-4-(2-(cyclopropylmethoxy) ethyl) phenoxy!propylamino!propionamido!phenyl!-5-methyl-4,5-dihydro-3 (2H)-pyridazinone.
2-(3-Amino-2-hydroxy-propoxy)-mono-and diazines
-
, (2008/06/13)
Heterocyclic compounds of the formula STR1 wherein Het denotes optionally substituted pyridazinyl, pyrimidinyl, pyrazinyl or substituted pyridyl, R1 is hydrogen or methyl and R2 is lower alklyl, optionally substituted phenyl-lower alkyl, carboxy-lower alkyl or functionally modified carboxy-lower alkyl, their condensation products with aldehydes, ketones or carbonic acid and their N-oxides, which are valuable (cardioselective) β-receptor blocking agents, and/or (cardioselective) β-receptor-stimulants.
2-(3-AMINO-2-HYDROXY-PROPOXY)-PYRAZINES
-
, (2008/06/13)
Heterocyclic compounds of the formula STR1 wherein Het denotes optionally substituted pyridazinyl, pyrimidinyl, pyrazinyl or substituted pyridyl, R 1 is hydrogen or methyl and R 2 is lower alkyl, optionally substituted phenyl-lower alkyl, carboxy-lower alkyl or functionally modified carboxy-lower alkyl, their condensation products with aldehydes, ketones or carbonic acid and their N-oxides, which are valuable (cardioselective) β-rezeptor blocking agents, and/or (cardioselective) β-rezeptor-stimulants.
